Phenylketonuria Treatment Market Size, Share & Trends Analysis Report By Drug (Kuvan, Palynziq, CNSA-001, SYNB1618), By Region (North America, APAC, Europe, MEA), And Segment Forecasts, 2019 - 2026

Table of Contents

Chapter 1 Research Methodology & Scope
1.1 Information Procurement
1.1.1 Purchased database:
1.1.2 GVR的内部数据库
1.2 Research Methodology
1.3 Geographic scope & assumptions
1.4 Region-wise market calculation
1.4.1 Region-wise market: Base estimates
1.4.2 Global market: CAGR calculation
1.5 Region-based segment share calculation
1.6 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Increasing prevalence of phenylketonuria
3.1.1.2 Presence of pipeline drugs
3.1.1.3 Rising collaborations among key market players
3.1.2 Market restraint analysis
3.1.2.1 High cost of treatment
3.1.2.2 Stringent government regulations
3.2 Phenylketonuria treatment - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
3.3 Industry Analysis - Porter’s
Chapter 4 Market Categorization 1: Drug Estimates & Trend Analysis
4.1 Phenylketonuria Treatment Market: Drugs Movement Analysis
4.2 Kuvan
4.2.1 Kuvan market, 2015 - 2026 (USD Million)
4.3 Palynziq
4.3.1 Palynziq market, 2015 - 2026 (USD Million)
4.4 CNSA-001
4.4.1 CNSA-001 market, 2015 - 2026 (USD Million)
4.5 SYNB1618
4.5.1 SYNB1618 market, 2015 - 2026 (USD Million)
Chapter 5 Market Categorization 2: Regional Estimates & Trend Analysis, by Product & Type
5.1 Phenylketonuria Treatment Market Share by Region, 2018 & 2026
5.2 North America
5.2.1 North America phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.2.2 U.S.
迴圈美国苯丙酮尿治疗市场,2015年- 2026 (USD Million)
5.2.3 Canada
5.2.3.1 Canada phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.3 Europe
5.3.1 Europe phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.3.2 U.K.
5.3.2.1 U.K. phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.3.3 Germany
5.3.3.1 Germany phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.3.4 Turkey
5.3.4.1 Turkey phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.3.5 Ireland
5.3.5.1 Ireland phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.4.2 Japan
5.4.2.1 Japan phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.4.3 China
5.4.3.1 China phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.4.4 India
5.4.4.1 India phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.5 Latin America
5.5.1 Latin America phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.5.3 Mexico
5.5.3.1 Mexico phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.6 MEA
5.6.1 MEA phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.6.2 Saudi Arabia
5.6.2.1 Saudi Arabia phenylketonuria treatment market, 2015 - 2026 (USD Million)
5.6.2 United Arab Emirates
5.6.2.1 United Arab Emirates phenylketonuria treatment market, 2015 - 2026 (USD Million)
Chapter 6 Competitive Landscape
6.1 Strategy framework
6.2 Market participation categorization
6.3 Company profiles
6.3.1 BioMarin Pharmaceutical Inc.
6.3.1.1 Company overview
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic insights
6.3.2 Synlogic, Inc.
6.3.2.1 Company overview
6.3.2.2 Financial Performance.
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Retrophin, Inc.
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Daiichi Sankyo Company, Limited
6.3.4.1 Company overview
6.3.4.2 Financial performance
6.3.4.3 Product benchmarking
6.3.4.4 Strategic initiatives
6.3.5 Codexis, Inc.
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic insights
6.3.6 SOM Innovation Biotech SL
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 Homology Medicines, Inc.
6.3.7.1 Company overview
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives

List of Tables

TABLE 1 North America phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 2 U.S. phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 3 Canada phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 4 Europe phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 5 U.K. phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 6 Germany phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 7 Turkey phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 8 Ireland phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 9 Asia Pacific phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 10 Japan phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 11 China phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 12 India phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 13 Latin America phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 14 Brazil phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 15 Mexico phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 16 MEA phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 17 UAE phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)
TABLE 18 Saudi Arabia phenylketonuria treatment market, by Drugs, 2015 - 2026 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Market summary
FIG. 4 Market segmentation & scope
FIG. 5 Market size and growth prospects
FIG. 6 Global phenylketonuria treatment market - Key market driver analysis
FIG. 7 Global phenylketonuria treatment market - Key market restraint analysis
FIG. 8 Penetration & growth prospect mapping
FIG. 9 Global phenylketonuria treatment market - Porter’s analysis
FIG. 10 Global phenylketonuria treatment market - PESTEL analysis
FIG. 11 Global phenylketonuria treatment market drug outlook key takeaways
FIG. 12 Global phenylketonuria treatment market: Drug movement analysis
FIG. 13 Regional market place: Key takeaways
FIG. 14 Global phenylketonuria treatment market: Regional movement analysis
FIG. 15 North America phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 16 U.S. phenylketonuria treatment market, 2015 - 2026 (USD Million)
图17加拿大phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 18 Europe phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 19 U.K. phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 20 Germany phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 21 Turkey phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 22 Ireland phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 23 Asia Pacific phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 24 Japan phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 25 China phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 26 India phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 27 Latin America phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 28 Brazil phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 29 Mexico phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 30 MEA phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 31 UAE phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 32 Saudi Arabia phenylketonuria treatment market, 2015 - 2026 (USD Million)
FIG. 33 Strategy framework